TC Biopharm (Holdings) Plc (TCBP)
NASDAQ: TCBP · Real-Time Price · USD
0.634
+0.004 (0.70%)
Nov 21, 2024, 12:33 PM EST - Market open
TC Biopharm (Holdings) Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -8.59 | -5.91 | -1.31 | -13.58 | -5.46 | -6.07 |
| Depreciation & Amortization | 0.77 | 0.82 | 0.96 | 1.01 | 1.08 | 0.9 |
| Other Amortization | 0 | 0 | 0.01 | 0.02 | - | - |
| Loss (Gain) From Sale of Assets | - | - | 0.01 | - | - | 0.01 |
| Stock-Based Compensation | 1.09 | 0.44 | 1.12 | - | 0.8 | 0.84 |
| Other Operating Activities | -4.33 | -7.26 | -9.18 | 7.2 | 0.07 | -0.6 |
| Change in Accounts Receivable | -1.28 | -1.28 | -0.04 | -0.59 | 1.73 | 0.26 |
| Change in Accounts Payable | 1.85 | 2.27 | -1.94 | 2.34 | 0.33 | -0.04 |
| Change in Unearned Revenue | - | - | -3.84 | -1.98 | -1.98 | -2.03 |
| Change in Income Taxes | 0.97 | 0.68 | -0.31 | - | - | - |
| Change in Other Net Operating Assets | -0.51 | -0.32 | -0.76 | - | - | - |
| Operating Cash Flow | -10.04 | -10.54 | -15.29 | -5.58 | -3.43 | -6.73 |
| Capital Expenditures | 0.01 | -0.11 | -0.24 | -0.02 | -0.03 | -2.03 |
| Sale of Property, Plant & Equipment | - | - | 0.06 | - | - | - |
| Sale (Purchase) of Intangibles | -0.08 | -0.1 | -0.12 | -0.12 | -0.17 | -0.17 |
| Investing Cash Flow | -0.07 | -0.21 | -0.31 | -0.14 | -0.2 | -2.2 |
| Short-Term Debt Issued | - | 5.13 | 18.82 | 6.38 | - | - |
| Long-Term Debt Issued | - | - | - | - | - | 0.32 |
| Total Debt Issued | 5.13 | 5.13 | 18.82 | 6.38 | - | 0.32 |
| Short-Term Debt Repaid | - | - | -2.63 | - | - | - |
| Long-Term Debt Repaid | - | - | - | -0.12 | -0.42 | -0.18 |
| Total Debt Repaid | - | - | -2.63 | -0.12 | -0.42 | -0.18 |
| Net Debt Issued (Repaid) | 5.13 | 5.13 | 16.19 | 6.26 | -0.42 | 0.14 |
| Issuance of Common Stock | 3.75 | 4.19 | 3.37 | 0.29 | 3.9 | 3.14 |
| Other Financing Activities | -3.38 | -0.79 | -0.91 | -0.02 | -0.05 | - |
| Financing Cash Flow | 5.5 | 8.52 | 18.65 | 6.53 | 3.43 | 3.27 |
| Foreign Exchange Rate Adjustments | -0.11 | -0.11 | 0.19 | 0.02 | -0 | -0.06 |
| Net Cash Flow | -4.72 | -2.35 | 3.24 | 0.82 | -0.21 | -5.71 |
| Free Cash Flow | -10.03 | -10.66 | -15.53 | -5.6 | -3.47 | -8.76 |
| Free Cash Flow Margin | - | - | -404.03% | -283.07% | -175.21% | -255.52% |
| Free Cash Flow Per Share | -152.00 | -344.92 | - | - | - | - |
| Cash Interest Paid | - | - | - | 0.25 | 0.29 | 0.09 |
| Cash Income Tax Paid | - | - | - | -1.18 | -1.24 | 0.02 |
| Levered Free Cash Flow | - | -12.23 | -8.3 | -4.3 | -0.74 | - |
| Unlevered Free Cash Flow | - | -12.18 | -4.08 | -2.15 | -0.56 | - |
| Change in Net Working Capital | - | 4.34 | -1.75 | -1.52 | -2.07 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.